Arlington Financial Advisors LLC Has $1.84 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Arlington Financial Advisors LLC increased its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 0.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 22,685 shares of the exchange traded fund’s stock after buying an additional 181 shares during the quarter. Arlington Financial Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,840,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in the business. Demars Financial Group LLC acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth $280,309,000. BlueCrest Capital Management Ltd acquired a new stake in SPDR S&P Biotech ETF during the 4th quarter worth $138,051,000. Mirae Asset Securities USA Inc. raised its stake in SPDR S&P Biotech ETF by 66.7% during the 4th quarter. Mirae Asset Securities USA Inc. now owns 1,500,000 shares of the exchange traded fund’s stock worth $135,090,000 after buying an additional 600,000 shares during the period. Bessemer Group Inc. increased its holdings in SPDR S&P Biotech ETF by 5.7% during the 4th quarter. Bessemer Group Inc. now owns 1,376,834 shares of the exchange traded fund’s stock worth $123,997,000 after purchasing an additional 73,866 shares in the last quarter. Finally, RA Capital Management L.P. bought a new position in SPDR S&P Biotech ETF during the 4th quarter worth about $110,615,000.

SPDR S&P Biotech ETF Trading Down 1.4%

XBI stock opened at $79.30 on Monday. The stock has a 50-day moving average price of $78.36 and a two-hundred day moving average price of $86.97. The stock has a market cap of $5.00 billion, a PE ratio of 11.47 and a beta of 0.91. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.